Zobrazeno 31 - 40
of 990
pro vyhledávání: ''
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background Primary hepatic neuroendocrine tumors (PH-NETs) are extremely rare and unknown. Because of its rarity, its prognosis features and influencing factors are not well established. Methods Data of 140 patients with PH-NETs diagnosed in the SEER
Autor:
Haixiao Wu, Xu Guo, Wenjuan Ma, Zheng Liu, Vladimir P. Chekhonin, Dezheng Wang, Chao Zhang, Jin Zhang, Yao Xu, Shuang Zhang, Karl Peltzer, Xin Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background This study aimed to describe the incidence, clinical characteristics, and prognosis of lung cancer patients with synchronous bone metastasis (SBM) and to analyze the prognostic factors of the lung cancer patients with SBM. Methods A total
Autor:
Meirong Liang, Qiaoling Zhu, Hong Lu, Wei Li, Wei Jiang, Yanan Wang, Wei Cheng, Li Xiong, Meiling Zhong
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background The assessment of retroperitoneal lymph node status in patients with locally advanced cervical cancer is still a problem. This study aimed to explore the choice of these assessment methods. Methods Laparoscopic retroperitoneal lymphadenect
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background This retrospective study aimed to evaluate the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with stereotactic body radiation therapy (SBRT) and to elucidate potential mechanisms of acquired resistan
Autor:
Jendrik Hardes, Arne Streitbürger, Stéphane Collaud, Theresa Stork, Rebecca Boemans, Christoph Pöttgen, Hans-Ulrich Schildhaus, Uta Dirksen, Clemens Aigner, Sebastian Bauer
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Cancer
BMC Cancer
Background Pulmonary metastasectomy (PM) is an established treatment for selected patients with metastatic sarcomas. The aim of this study was to examine our institutional experience and evaluate factors predicting outcome. Methods We retrospectively
Autor:
Keisuke Yoshida, Takayuki Okamoto, Yumi Matsuyama, Tomoki Nakamura, Kunihiro Asanuma, Tomohito Hagi, Kouji Kita, Koichi Nakamura, Yumiko Asanuma, Akihiro Sudo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background The intimate relationship between coagulation and fibrinolysis in malignant tumors is a well-known phenomena, with the malignant phenotype enhancing coagulation and fibrinolysis. We hypothesized that soft tissue sarcoma (STS) affects the e
Autor:
Guido Scoccianti, Reinhard Windhager, Alberto Schiavo, P. D. Sander Dijkstra, Maria Anna Smolle, Catrin Wigley, Francesco Muratori, Mariia Kukushkina, Pierluigi Cuomo, Valentina Tortolini, Domenico Andrea Campanacci, Philipp T. Funovics, Tamás Perlaky, Daniel Müller, Davide Matera, Jorrit Jasper, Marie-Theres Lingitz, Dominik Kaiser, Andreas Leithner
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer, 21(1). BMC
BMC Cancer
BMC Cancer, 21(1). BMC
BMC Cancer
Background Extra-abdominal desmoid tumor fibromatosis (DTF) is a rare, locally aggressive soft tissue tumour. The best treatment modality for this patient cohort is still object of debate. Questions/purpose This paper aimed to (1) to compare the outc
Autor:
Shirley Lee, Hanif Abdul Rahman, Lin Naing, Nadiah 'Aqilah Abidin, Sok King Ong, Elvynna Leong
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Cancer
BMC Cancer
BACKGROUND Colorectal cancer (CRC) is a major cause of cancer-related mortality worldwide. It is the second leading cause of cancer death in men and women in Brunei Darussalam in 2017, posing a major burden on society. METHODS This retrospective coho
Autor:
Deborah M. Scharf, Anna Pefoyo Kone
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer
BMC Cancer
Background The majority of people with cancer have at least one other chronic health condition. With each additional chronic disease, the complexity of their care increases, as does the potential for negative outcomes including premature death. In th
Publikováno v:
BMC Cancer. 22
BackgroundThis study was designed to investigate the impact of anti-tumor approaches (including chemotherapy, targeted therapy, endocrine therapy, immunotherapy, surgery and radiotherapy) on the outcomes of cancer patients with COVID-19.MethodsElectr